Open AccessRelationship between serum b2-microglobulin levels and virological breakthrough in HBeAg-negative chronic hepatitis B patients, under long-term treatment schedules including lamivudine
Author(s) -
Ioannis Elefsiniotis,
Antonios Moulakakis,
Konstantinos Pantazis,
Irene Glynou,
Ioannis Ketikoglou,
Elena Vezali,
Helen Kada,
Epameidas V. Tsianos
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i13.1922
Subject(s) - medicine , gastroenterology , beta 2 microglobulin , lamivudine , hbeag , hepatitis b , proportional hazards model , hbsag , chronic hepatitis , immunology , hepatitis b virus , virus
Predictive value of serum b2-microglobulin (b2m) levels for virological breakthrough (VB) in HBeAg-negative chronic hepatitis B (CHB) patients under long-term treatment schedules including lamivudine (LAM).